BLV: lessons on vaccine development
Vaccination against retroviruses is a challenge because of their ability to stably integrate into the host genome, undergo long-term latency in a proportion of infected cells and thereby escape immune response. Since clearance of the virus is almost impossible once infection is established, the prim...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | info:ar-repo/semantics/artículo |
| Lenguaje: | Inglés |
| Publicado: |
BMC
2019
|
| Materias: | |
| Acceso en línea: | https://retrovirology.biomedcentral.com/articles/10.1186/s12977-019-0488-8 http://hdl.handle.net/20.500.12123/6118 https://doi.org/10.1186/s12977-019-0488-8 |
Ejemplares similares: BLV: lessons on vaccine development
- Vaccination against δ-retroviruses : the bovine leukemia virus paradigm
- Recent advances in BLV research
- A safe and effective vaccine against bovine leukemia virus
- Evaluation of serological response to foot-and-mouth disease vaccination in BLV infected cows
- An efficient vaccine against bovine leukemia virus
- Double-layered rotavirus-like particles are efficient carriers to elicit strong CTL responses to delivered heterologous antigens